In support of a PVR blockade strategy, studies in acute myeloid leukemia (AML) and melanoma cell lines as well asin vivo murine tumor models resulted, respectively, in the activation of anti-tumoral cell types and avoidance of metastases (Figure 2, B). The gene discussed is PVR; the disease is acute myeloid leukemia.